304 related articles for article (PubMed ID: 35203418)
1. Induced Pluripotent Stem Cells for Treatment of Alzheimer's and Parkinson's Diseases.
Yefroyev DA; Jin S
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203418
[TBL] [Abstract][Full Text] [Related]
2. Modelling neurodegenerative diseases with 3D brain organoids.
Chang Y; Kim J; Park H; Choi H; Kim J
Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
[TBL] [Abstract][Full Text] [Related]
3. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
Marotta N; Kim S; Krainc D
Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
[No Abstract] [Full Text] [Related]
4. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
[TBL] [Abstract][Full Text] [Related]
5. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
Okano H; Morimoto S
Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapy for Parkinson's disease: safety and modeling.
Stoddard-Bennett T; Pera RR
Neural Regen Res; 2020 Jan; 15(1):36-40. PubMed ID: 31535640
[TBL] [Abstract][Full Text] [Related]
7. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
9. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects of stem cell therapy in Alzheimer's disease.
Zhang FQ; Jiang JL; Zhang JT; Niu H; Fu XQ; Zeng LL
Neural Regen Res; 2020 Feb; 15(2):242-250. PubMed ID: 31552889
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
[TBL] [Abstract][Full Text] [Related]
13. Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting.
Teli P; Kale V; Vaidya A
Cell Tissue Res; 2023 Oct; 394(1):75-91. PubMed ID: 37572163
[TBL] [Abstract][Full Text] [Related]
14. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
[TBL] [Abstract][Full Text] [Related]
15. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
Lee C; Willerth SM; Nygaard HB
Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
17. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
Pen AE; Jensen UB
Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
[TBL] [Abstract][Full Text] [Related]
18. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells.
Kim MS; Kim H; Lee G
Adv Healthc Mater; 2024 Jan; ():e2303041. PubMed ID: 38269602
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]